TB vaccine study for teens and adults
Treatments studied
Part of Infections clinical trials.
This trial tests whether a new vaccine called MTBVAC can prevent tuberculosis (TB) in people living in areas where TB is common. If you are between 14 and 45 years old and in good health, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 to 45 years old.
- You are in good general health.
- You have not lived with someone who has TB in the past 6 months.
- You test negative for HIV and active TB at screening.
- If you are female and could become pregnant, you agree to use birth control for 2 months after vaccination.
- You have not had TB disease or treatment for TB before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests MTBVAC, a TB vaccine candidate, to see if it is safe and whether it helps the immune system. It may be a fit if you’re eligible for TB and HIV-related vaccine safety testing and can follow study visits and testing.
This study tests a new tuberculosis (TB) vaccine (ID93+GLA-SE) in healthy adults aged 55 to 74. It aims to see if the vaccine is safe and can help protect against TB, especially in people who may have latent (inactive) TB infection.
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
This study tests a new tuberculosis vaccine called Lipovaxin in healthy adults aged 18–40. Researchers want to see if it is safe and how the body responds to it, which could help prevent TB infection in the future.
This study screens people for tuberculosis (TB), a serious lung infection, using new testing methods. Researchers want to find TB cases early so people can get treatment before the disease becomes severe.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.